在年轻和老年患者特定的大动脉模型中,磁性药物向的年龄相关效率
Seyed Behzad Hosseini1, Wala Almosawy2,3, Rasoul Karimi Takrami4
1Department of Engineering, University of Florence, Florence, Italy.
Scientific reports
|February 9, 2026
概括
血管衰老提高了磁性药物向 (MDT) 的效率,由于改变了血液动力学. 老年患者表现出更好的捕获效率,这表明以年龄为基础的MDT优化对于更好的治疗提供至关重要.
科学领域:
- 生物医学工程 生物医学工程
- 计算流体动力学的流体动力学.
- 血管生物学 血管生物学
背景情况:
- 磁性药物向 (MDT) 是血管疾病的有前途的局部治疗方法.
- 与年龄相关的血液动力学变化可以显著影响MDT的性能.
- 针对患者的特定计算模型对于理解这些影响至关重要.
研究的目的:
- 为了比较年轻人与老年患者的MDT表现,针对特定患者的大动脉模型.
- 为了研究非牛顿式血液类风湿学对MDT的影响.
- 为了评估不同磁场强度对纳米粒子捕获效率的影响.
主要方法:
- 在患者特定的大动脉模型中模拟纳米粒子运动的计算框架.
- 通过非牛顿式的风力学 (卡罗,权力定律,卡森-帕帕纳斯塔西奥) 建模血液流动.
- 在磁场 (0.5-1.5 T) 下模拟纳米粒子行为.
主要成果:
- 捕获效率 (CE) 在所有模型中随着粒子大小和磁场强度的增加而增加.
- 老年患者的CE略高于年轻患者,这是由于减速和变化的流动力学.
- 非牛顿模型预测的CE低于牛顿模型;使用了临床安全的磁场强度.
结论:
- 血管衰老在现实的血液动力学条件下增强磁性药物捕获.
- 与年龄相关的血液动力学变化积极影响MDT的性能.
- 为了有效的MDT策略,需要针对患者的,针对年龄的优化.
更多相关视频
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
713
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
713
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
264
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
264
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
223
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
259
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
259
Drug Dependence
1.7K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.7K
Pharmacodynamics in Geriatric Patients: Effects of Age
241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241


